| 名稱 | NAT2*5 Reference Standard |
| 型號(hào) | CBPA0066 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | NAT2*5 Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- CYP2C9基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP1A1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- VKORC1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- MTHFR基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP2D6基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP2C19基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 特應(yīng)性皮炎(AD)賽道新治療——OX40靶點(diǎn)
- THR-β激動(dòng)劑：NASH治療的新希望？
- 3年回顧，賀教授敲錯(cuò)了基因？CXCR4 or CCR5
- 選擇性組蛋白去乙酰化酶抑制劑在腫瘤免疫治療中的作用及前景
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > 用藥指導(dǎo) > CBPA0066NAT2*5 Reference Standard
- 詳細(xì)內(nèi)容
| CBPA0066 | |
| Format | Genomic DNA |
| Description | NAT2 (N-Acetyltransferase 2) is a Protein Coding gene. Diseases associated with NAT2 include Acetylation, Slow and Multiple Chemical Sensitivity. |
| Technical Data | |
| Gene | NAT2 |
| AA Change | p.I114N |
| DNA Change | NM_000015.3:c.341T>A |
| Chr position (GRCh38) | NC_000008.11:g.18400344T>A |
| Allelic Frequency | 50% |
| Zygosity | Heterozygous |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 4°C |
| Expiry | 36 months from the date of manufacture |
會(huì)員_a.png)